RAVINDER MAMEDI: Open Payments
NPI 1972554541 · ROANOKE RAPIDS, NC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,026 in 124 payments from 12 companies in 2025. Trend: 2023 $1,751 · 2024 $2,019 · 2025 $2,026
Food & beverage: $1,842Education: $183
| Company | Payments | Amount |
|---|---|---|
| Janssen Pharmaceuticals, Inc | 23 | $408 |
| Alkermes, Inc. | 22 | $326 |
| Teva Pharmaceuticals USA, Inc. | 12 | $285 |
| Otsuka America Pharmaceutical, Inc. | 16 | $273 |
| ABBVIE INC. | 17 | $218 |
| Neurocrine BioSciences, Inc. | 9 | $158 |
| Vanda Pharmaceuticals Inc. | 13 | $138 |
| Lundbeck LLC | 4 | $82 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 4 | $67 |
| E.R. Squibb & Sons, L.L.C. | 2 | $35 |
Products named: ARISTADA, REXULTI, VRAYLAR, INVEGA SUSTENNA, SPRAVATO, INGREZZA, FANAPT, CAPLYTA.
Industry payments across NC — which companies pay providers there.
